2005
DOI: 10.1038/sj.npp.1300908
|View full text |Cite
|
Sign up to set email alerts
|

Differential Regulation of the Consummatory, Motivational and Anticipatory Aspects of Feeding Behavior by Dopaminergic and Opioidergic Drugs

Abstract: Various aspects of feeding behavior (eg consumption, motivation and anticipation) are regulated by homeostatic and hedonic systems, and are modulated by dopaminergic and opioid brain systems. Here, we have studied the modulation of these aspects of feeding behavior by opioid and dopaminergic neurotransmission while taking into account food palatability and homeostatic state. Foods that varied in palatability were presented to either food sated or food restricted rats following injections of different doses of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

9
80
1
2

Year Published

2006
2006
2022
2022

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 113 publications
(92 citation statements)
references
References 67 publications
9
80
1
2
Order By: Relevance
“…Our finding that the food-paired context acquired the ability to evoke a conditioned locomotor response is consistent with observations (Bindra, 1968) that environmental stimuli paired with primary reinforcers stimulate locomotor activity, an effect that has been repeatedly confirmed (Jones and Robbins, 1992;Hayward and Low, 2005;Barbano and Cador, 2006). Furthermore, the locomotor activity observed in food-sensitized animals exposed to the food-paired context when food was omitted, was similar in amplitude to their activity measured when food was available.…”
Section: Discussionsupporting
confidence: 90%
“…Our finding that the food-paired context acquired the ability to evoke a conditioned locomotor response is consistent with observations (Bindra, 1968) that environmental stimuli paired with primary reinforcers stimulate locomotor activity, an effect that has been repeatedly confirmed (Jones and Robbins, 1992;Hayward and Low, 2005;Barbano and Cador, 2006). Furthermore, the locomotor activity observed in food-sensitized animals exposed to the food-paired context when food was omitted, was similar in amplitude to their activity measured when food was available.…”
Section: Discussionsupporting
confidence: 90%
“…The differential actions of nalmefene on chow intake according to diet history support the hypothesis that opioids also participate in learned associative, appetitive processes that underlie food acceptance and selection (Barbano and Cador, 2006;Jarosz et al, 2006;Kas et al, 2004). This conclusion differs from prevailing views that opioid-receptor antagonists simply are anorectic per se (especially for palatable food) or modulate putative 'intrinsic' hedonic properties of foods (Cooper, 2004;de Zwaan and Mitchell, 1992).…”
Section: Discussionmentioning
confidence: 54%
“…For example, motivation or 'wanting' for food is linked with opioid-and dopaminergicmediated signaling within the nucleus accumbens (see reference Berridge et al (2009) for review). Mu-opioid receptor antagonists (eg b-funaltrexamine (BFNA), naloxone) administered either directly into the nucleus accumbens shell (Shin et al, 2010) or peripherally (Wakonigg et al, 2003;Barbano and Cador, 2006) increase the runway time to obtain food. In these studies the increased runway time by opioid receptor blockade either did not differ across trials (Shin et al, 2010) or was enhanced on later trials compared with earlier trials (Wakonigg et al, 2003;Barbano and Cador, 2006).…”
Section: Discussionmentioning
confidence: 99%
“…Mu-opioid receptor antagonists (eg b-funaltrexamine (BFNA), naloxone) administered either directly into the nucleus accumbens shell (Shin et al, 2010) or peripherally (Wakonigg et al, 2003;Barbano and Cador, 2006) increase the runway time to obtain food. In these studies the increased runway time by opioid receptor blockade either did not differ across trials (Shin et al, 2010) or was enhanced on later trials compared with earlier trials (Wakonigg et al, 2003;Barbano and Cador, 2006). This contrasts with the effect of VHPC leptin on runway performance in the present study, which increased the latency to start on early but not later trials relative to vehicle treatment.…”
Section: Discussionmentioning
confidence: 99%